Pexa AB logo

Pexa AB (PEXA.B)

Market Closed
XSTO XSTO
kr
kr
17.33M Market Cap
- P/E Ratio
- Div Yield
- Volume
- Eps
kr
Previous Close
Add Transaction
Day Range
0 0
Year Range
0 0
Want to track PEXA.B and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

PEXA.B is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

PEXA.B Chart

People also search for

OncoZenge AB
kr 5.75
-7.4074%
FRISQ Holding AB
kr 0.7
+6.383%
ScandiDos AB
kr 0.92
+2.809%
GPX Medical AB
kr 2.13
-0.9302%
Redsense Medical AB
kr 4
+0.2506%

Pexa AB (PEXA.B) FAQ

What is the stock price today?

The current price is kr0.00.

On which exchange is it traded?

Pexa AB is listed on XSTO.

What is its stock symbol?

The ticker symbol is PEXA.B.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 17.33M.

Has Pexa AB ever had a stock split?

No, there has never been a stock split.

Pexa AB Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Mr. Tomas Gustafsson CEO
XSTO Exchange
- ISIN
Sweden Country
3 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

PExA AB (publ) specializes in the development and commercialization of diagnostic tools for a wide spectrum of respiratory diseases, including asthma, tuberculosis, cystic fibrosis, lung cancer, chronic airway inflammation, and chronic obstructive pulmonary diseases (COPDs). Leveraging advanced research instruments, the company has a strong focus on facilitating lung researchers in collecting microscopic particles and biomarkers from the small airways, which are critical in early disease detection and management. Established in 2014, with its headquarters situated in Gothenburg, Sweden, PExA AB stands at the forefront of noninvasive pulmonary diagnostics. The company has established prominent research collaboration agreements with high-caliber entities like Janssen Research & Development, LLC, and the University of Gothenburg, aimed at uncovering new biomarkers in exhaled breath, showcasing its commitment to advancing respiratory disease research and diagnostics.

Products and Services

  • PExA 2.0
  • This cutting-edge instrument is designed for the non-invasive collection of particles in exhaled air, presenting a significant advancement in respiratory diagnostics. The PExA 2.0 system allows for the safe and efficient gathering of biological markers from the lungs, aiding in the early detection and management of various pulmonary diseases. Its non-invasive nature makes it particularly valuable in clinical settings, offering a patient-friendly alternative to traditional diagnostic methods.

  • Accessories
  • To support and enhance the functionality of the PExA 2.0 instrument, PExA AB provides a comprehensive range of accessories. This includes substrate surfaces for collecting exhaled particles, various nozzle designs to accommodate different use cases, and essential parts and service kits to ensure the longevity and optimal performance of the instruments. These accessories are integral to the PExA system, ensuring versatility and ease of integration into different research settings.

  • Support Services
  • Understanding the complexities and challenges of lung research and diagnostics, PExA AB offers extensive support services to its clients. This encompasses technical support, maintenance, and training on the usage of its PExA 2.0 instrument and accessories. By providing these services, the company ensures that lung research centers, academia, and pharmaceutical companies can maximize the utility of PExA technology in their ongoing research and diagnostic endeavors.

Contact Information

Address: Arvid Wallgrens Backe 20
Phone: 46 7 05 86 43 80
Website: https://pexa.se